ONXX Financial Facts
Net loss: -33.67MInterest expense: -5.63M
See Full Income Statement
Accounts payable: 2.72M
Prepaid expenses and other current assets: 33.73M
See Full Balance Sheet
Earnings History for Onyx Pharmaceuticals Inc. (ONXX)
|
Expand Research on ONXX
| Next EPS Date | 7/31/13 *Est. | EPS Growth Rate | +72.1% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +30.2% | Revenue Growth Rate | +102.1% *Last Qtr. |
| Average % Move 1-Wk after EPS | +2.3% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/7/13  |
 |
Q113 | -$0.19 | -$0.47 | +$0.28 | $145.5M | $134.36M | N/A / N/A | N/A | +5.5% | Details |
| 11/1/12 |
|
Q312 | -$0.79 | -$0.90 | +$0.11 | $89.51M | $80.02M | N/A / N/A | N/A | +18.7% | Details |
| 8/1/12 |
Q212 | -$0.68 | -$0.66 | -$0.02 | $72.7M | $72.07M | N/A / N/A | N/A | +29.9% | Details | |
| 2/21/13 |
|
Q412 | -$0.36 | -$0.75 | +$0.39 | $127.9M | $113.17M | N/A / N/A | N/A | +35.7% | Details |
| 5/2/12 |
|
Q112 | -$0.68 | -$0.55 | -$0.13 | $72M | $69.82M | N/A / N/A | N/A | +111.2% | Details |
| 11/2/11 |
|
Q311 | -$0.31 | -$0.19 | -$0.12 | $75.04M | $80.38M | N/A / N/A | N/A | +141.8% | Details |
| 2/22/12 |
|
Q411 | $1.50 | $1.43 | +$0.07 | $237M | $213.24M | N/A / N/A | N/A | +151.9% | Details |
| 5/4/11 |
|
Q111 | -$0.02 | -$0.13 | +$0.11 | $67.15M | $70.36M | N/A / N/A | N/A | +157.2% | Details |
